-
Diagnostics World News Brief | Butterfly Network, a project of Jonathan Rothberg, has announced that it has developed a novel augmented reality telemedicine technology on Butterly iQ, the world's first whole-body ultrasound imager. Butterfly iQ is a personal ultrasound device and sells for less than $2,000. Using Butterfly Tele-Guidance technology, an ultrasound expert can remotely guide any user to acquire even the most challenging ultrasound scans, bringing medical expertise to wherever it's needed most.
Mar 26, 2018
-
Diagnostics World Contributed Commentary | In the research community, metagenomics has yielded new insights into microbial communities and emerging pathogens, giving scientists reams of novel information about everything from optimal soil for crop production to new means of tracking criminal activity. Now, clinical labs are beginning to adopt metagenomics, with consequences that may be just as game-changing for diagnosing and treating patients with infectious diseases.
Mar 23, 2018
-
Diagnostics World | The US Food and Drug Administration has granted the De Novo request for the commercialization of Banyan BTI (Brain Trauma Indicator), an in vitro diagnostic blood test to aid in the evaluation of adult patients with suspected traumatic brain injury.
Mar 21, 2018
-
Xconomy |
The Centers for Medicare & Medicaid Services, which administers the federal Medicare insurance program, will begin covering FDA-approved diagnostic tests that scan tumors for a range of genetic mutations.
Mar 19, 2018
-
Diagnostics World | Medial EarlySign recently announced the results of a clinical data study in which their machine-learning based model was able to analyze Electronic Health Records and identify diabetic patients who are at the highest risk for having kidney disease within one year.
Mar 19, 2018
-
Diagnostics World | Representatives of academic institutions, pharma, and biotech companies responded to a recent survey saying that companion diagnostics are vital to personalized medicine.
Mar 16, 2018
-
STAT | The charges cap off a remarkable downfall for a once high-flying company that promised to revolutionize the blood testing industry but instead became a parable for Silicon Valley hype and hubris.
Mar 14, 2018
-
Diagnostics World Contributed Commentary | Applications like monoclonal antibodies are advancing more rapidly than ever, and the industry needs to keep pace. But the methods we have relied on for the past century to develop and produce antibodies have been plagued by low affinity, low specificity, lack of repeatability, and long production times.
Mar 13, 2018
-
Psychiatric Times |
The amyloid-β42/40 (Aβ42/40) ratio should be included as a cerebrospinal fluid (CSF) biomarker for Alzheimer disease (AD) and may be appropriate for use in the clinical diagnostic setting, according to a new study. The findings suggest that analysis of Aβ40 as well as Aβ42 concentrations may provide greater sensitivity and specificity.
Mar 9, 2018
-
Diagnostics World News While the severity of any given flu season can vary widely, the burden is always substantial—lost time, lost productivity, and lost lives. And this year’s flu season has been particularly active. The viruses are elusive, evolving from one year to the next and even changing over the course of an individual season. When the H1N1 flu virus emerged back in 2009 after the seasonal vaccine had already been developed, the strain spread and caused a global outbreak. But diagnostics also played a role.
Mar 7, 2018
-
Diagnostics World News Brief | FDA today authorized a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian, and prostate cancer.
Mar 6, 2018
-
The Health Care Blog |
Through a quirk of fate, the very nature of breast screening programmes has provided a wealth of digitised imaging data extremely well documented with patient outcomes. This rich source of data just so happens to be perfect for the needs of deep learning. By leveraging labelled digital images and their associated final pathological outcomes, we can provide data scientists with a near-perfect 'ground truth' dataset.
Mar 5, 2018
-
Diagnostics World | February featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Curetis, Cofactor Genomics, Inflammatix, and more.
Feb 28, 2018
-
Diagnostics World | During the 25th annual Molecular Medicine Tri-Conference in San Francisco, Leroy Hood of the Institute for Systems Biology and Providence St. Joseph Health discussed his latest efforts to transform medicine through pioneering a systems-driven approach.
Feb 27, 2018
-
Diagnostics World | Gregory Simon, President of the Biden Cancer Initiative, discussed the current state of cancer treatment during his keynote address at the 25th annual Molecular Medicine Tri-Conference last week. “What I’m going to talk to you about today,” Simon said, “is changing the way we think about what we’re doing in [cancer] research.”
Feb 23, 2018